Protocol No.: STRO-001-BCM1

Title
A Phase I Open-Label, Safety, Pharmacokinetic, and Preliminary Efficacy Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients with Advanced B-Cell Malignancies
Principal Investigator
Veltri, Lauren
Phase
I
Age Group
Adult
Applicable Disease Sites
Lymphoma
Multiple Myeloma
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Sylvia McEwuen, RN, CCRC
Study Coordinator/Research Nurse
Phone: +1 304-293-1683

View on ClinicalTrials.gov